Experts: Government Should Call on Naloxone Makers to Reduce Costs

The government should call on manufacturers of the opioid overdose antidote naloxone to reduce the cost of the life-saving drug, experts write in this week’s New England Journal of Medicine.

Rising naloxone prices may threaten attempts to reduce opioid-related deaths, researchers from Yale University and the Mayo Clinic warn. “The challenge is as the price goes up for naloxone, it becomes less accessible for patients,” Ravi Gupta, the study’s lead author, told HealthDay.

Full story of Naxolone makers and costs at drugfree.org

Published by

Will Savage

Quantum Units Continuing Education provides online CEU training's to licensed professional mental health therapists, counselors, social workers and nurses. Our blog provides updates in the field of news and research related to mental health and substance abuse treatment.